https://medicalxpress.com/ en-us provides the latest news from University of Missouri School of Medicine Researchers from the University of Missouri School of Medicine have found potential treatments for two different types of common complications following bone marrow transplantation. https://medicalxpress.com/news/2024-02-potential-treatments-common-complication-bone.html Wed, 14 Feb 2024 15:03:03 EST news627145380 Research has shown that for working mothers, the ability to breastfeed their babies is critical to their physical, mental and economic health as well as to their babies' cognitive and physical development. The Affordable Care Act (ACA) requires employers of more than 50 employees to provide sufficient space and time for mothers to breastfeed during the first year of their babies' lives. Researchers from the University of Missouri conducted an analysis of ACA's requirement to determine if any barriers exist for women living in rural areas; they found a lack of compliance with the law, inadequate breastfeeding information for mothers and lack of support from co-workers and supervisors. The researchers suggest a need for collaboration between businesses and rural health agencies to create ACA friendly environments that remove barriers to breastfeeding in the workplace. https://medicalxpress.com/news/2016-09-rural-employers-breastfeeding-mothers.html Tue, 27 Sep 2016 05:01:26 EDT news394171260 A baby's skull is made of several plates of bone that fuse together over time to form a single structure. Previous research has shown that approximately one in 2,000 babies have plates that fuse too early—a condition called craniosynostosis—causing cranial deformities that can lead to learning impairments and other neurodevelopmental problems. Craniofacial surgeons across the country differ on when surgical intervention is needed for some abnormalities. Now, researchers at the University of Missouri School of Medicine are recommending a new method to help determine when surgery is needed. https://medicalxpress.com/news/2016-09-craniofacial-surgeons-children-skull-deformity.html Mon, 26 Sep 2016 17:38:38 EDT news394130314 According to the World Nuclear Association, more than 10,000 hospitals worldwide use radioisotopes in medicine. Molybdenum-99, the parent isotope of technetium-99m, is the most widely used radioisotope for the diagnosis and treatment of cancer. However, production costs and the limited viability of the isotope can be a challenge for clinicians and healthcare providers. Now, nuclear researchers at the University of Missouri are exploring alternate materials that could be used to help recycle the metals used to produce radioisotopes more efficiently and with less waste. Scientists believe this cheaper method could result in a cost savings for healthcare providers who could pass those savings on to patients. https://phys.org/news/2016-09-recycling-cancer-fighting-tools-vital-radioisotopes.html Mon, 26 Sep 2016 12:40:33 EDT news394112428 Millions of people with type 1 diabetes depend on daily insulin injections to survive. They would die without the shots because their immune system attacks the very insulin-producing cells it was designed to protect. Now, a University of Missouri scientist has discovered that this attack causes more damage than scientists realized. The revelation is leading to a potential cure that combines adult stem cells with a promising new drug. https://medicalxpress.com/news/2013-05-adult-stem-cells-key-diabetes.html Wed, 29 May 2013 15:01:53 EDT news289058502 Long after a hangover, a night of bad decisions might take a bigger toll on the body than previously understood. Described in the current issue of Alcoholism: Clinical & Experimental Research, a study at the University of Missouri has revealed a unique connection between binge drinking and the risk for developing alcoholic liver disease and a variety of other health problems. https://medicalxpress.com/news/2013-05-weekend-binge-liver.html Wed, 01 May 2013 12:02:55 EDT news286628565 (Medical Xpress)—A little more than a year after the FDA approved Kalydeco (Vx-770), the first drug of its kind to treat the underlying cause of cystic fibrosis, University of Missouri researchers believe they have found exactly how this drug works and how to improve its effectiveness in the future. Described in the current issue of the Proceedings of the National Academy of Sciences, MU researchers have redefined a key regulatory process in the defective protein responsible for cystic fibrosis that could change the way scientists approach the lethal genetic disease. https://medicalxpress.com/news/2013-03-discovery-efficacy-cystic-fibrosis-drug.html Thu, 21 Mar 2013 14:21:27 EDT news283094460 (Medical Xpress)—Muscular dystrophy is caused by the largest human gene, a complex chemical leviathan that has confounded scientists for decades. Research conducted at the University of Missouri and described this month in the Proceedings of the National Academy of Sciences has identified significant sections of the gene that could provide hope to young patients and families. https://medicalxpress.com/news/2013-01-scientists-needle-haystack-muscular-dystrophy.html Tue, 22 Jan 2013 15:11:27 EST news278089867 Scientists who study HIV are facing a troubling consequence of their own success. They created drugs that can now give infected patients almost normal life expectancy. However, those same drugs will eventually cause the constantly mutating virus to evolve into a form that eludes current treatments. https://medicalxpress.com/news/2013-01-hiv-defenses-drug-resistant-mutations-emerge.html Wed, 16 Jan 2013 16:16:46 EST news277575401 Researchers at the University of Missouri have demonstrated the effectiveness of a potential new therapy for stroke patients in an article published in the journal Molecular Neurodegeneration. Created to target a specific enzyme known to affect important brain functions, the new compound being studied at MU is designed to stop the spread of brain bleeds and protect brain cells from further damage in the crucial hours after a stroke. https://medicalxpress.com/news/2012-06-treatment-brain.html Mon, 11 Jun 2012 12:42:58 EDT news258637296